LogoLogo Light
  • Home
  • About EU-NN
    • EU-NN Board
    • Scientific Committee
    • Database Management Committee
    • EU-NN Database
    • Teaching Committee
  • Narcolepsy and CDH
    • What is Narcolepsy?
    • What are the symptoms of narcolepsy?
    • Who develops narcolepsy?
    • How is narcolepsy diagnosed?
    • How is narcolepsy treated?
    • What causes narcolepsy?
    • Narcolepsy in Children
    • Narcolepsy and Pregnancy
  • Care and Support
    • European sleep disorder centers
    • Patient Societies
  • Research
    • Publications
    • EU-NN Awards
    • EU-NN Career Awards
    • News
    • Networks
  • Events
  • Media
  • MEMBERS
    • Membership Application
    • Login
  • Contact
  • Support us
LogoLogo Light
  • Home
  • About EU-NN
    • EU-NN Board
    • Scientific Committee
    • Database Management Committee
    • EU-NN Database
    • Teaching Committee
  • Narcolepsy and CDH
    • What is Narcolepsy?
    • What are the symptoms of narcolepsy?
    • Who develops narcolepsy?
    • How is narcolepsy diagnosed?
    • How is narcolepsy treated?
    • What causes narcolepsy?
    • Narcolepsy in Children
    • Narcolepsy and Pregnancy
  • Care and Support
    • European sleep disorder centers
    • Patient Societies
  • Research
    • Publications
    • EU-NN Awards
    • EU-NN Career Awards
    • News
    • Networks
  • Events
  • Media
  • MEMBERS
    • Membership Application
    • Login
  • Contact
  • Support us

Blog

  • You are here:
  • Home
  • Measurement of symptoms in idiopathic hypersomnia. The Idiopathic Hypersomnia Severity Scale

Measurement of symptoms in idiopathic hypersomnia. The Idiopathic Hypersomnia Severity Scale

In a paper published this month in Neurology, the Idiopathic Hypersomnia Severity Scale (IHSS), a brief self-report instrument designed to measure the severity of the key symptoms of idiopathic hypersomnia (IH), was validated. If much is known in the field of narcolepsy, IH remains largely unknown. This central hypersomnia is characterized by severe excessive daytime sleepiness (EDS), prolonged nighttime sleep, and sleep inertia (i.e. difficulty in awakening from sleep, in the morning and after naps). EDS, the most common symptom, often occurs also in the general population with various phenotypes; and psychometric tools, as the widely used Epworth Sleepiness Scale, were developed to evaluate its severity. However, a specific instrument to assess the spectrum of IH symptoms was lacking so far.

IHSS is a 14-item self-administered questionnaire that assesses nighttime sleep symptoms and the related sleep inertia (5 items), daytime sleep symptoms and the related sleep inertia (4 items), and impaired daytime functioning due to hypersomnolence (5 items). All items are scored from 0 to 3 or 4, depending on severity, that provide a score, ranging from 0 to 50, with the highest score reflecting more severe and frequent symptoms. The psychometric properties, discriminant diagnostic validity, and score changes with treatment of the scale were assessed, after being administered to 210 participants from the French National Reference Center for central Hypersomnia. IHSS turned out to be a reliable and valid clinical tool for the quantification of IH symptoms and consequences. This questionnaire will be useful for future research for patients identification, follow-up, and management.

The Idiopathic Hypersomnia Severity Scale (IHSS) has been developed and is copyrighted by Professor Yves Dauvilliers. IHSS © Yves Dauvilliers, 2018. The IHSS is distributed worldwide by Mapi Research Trust, a not for profit organization, based in France. For any further information on the utilization of the IHSS, please contact Mapi Research Trust at:

https://eprovide.mapi-trust.org/instruments/idiopathic-hypersomnia-severity-scale

Y. Dauvilliers, E. Evangelista, L. Barateau, R. Lopez, S. Chenini, C. Delbos, S. Beziat, I. Jaussent. Measurement of symptoms in idiopathic hypersomnia. The Idiopathic Hypersomnia Severity Scale. Neurology. 2019 Apr 9;92(15):e1754-e1762. doi: 10.1212/WNL.0000000000007264. Epub 2019 Mar 13. https://www.ncbi.nlm.nih.gov/pubmed/30867266

Previous Post

Newsletter: Winter 2019

Next Post

Rules for Membership (version May 2019)
Last News
  • Daytime sleepiness and BMI exhibit gender and age differences in patients with central disorders of hypersomnolence
  • Narcolepsy risk loci outline role of T cell autoimmunity and infectious triggers in narcolepsy
  • EU-NN 2023 Awards
Scroll
@2017 eu-nn.com Powered by  GIMBO3D - Criative Factory
 
 
 
 
Forgot Password
Please enter your email address or username below.
 
Please Login
Lost Your Password
 
 
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.Accept Read More
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT